The intent of this clinical study is to answer the questions: 1) is the proposed treatment feasible; 2) is treatment effective in improving the disease pathology of patients with diagnosed diabetic erectile dysfunction.
Intracavernous transplantation of stem cells has been shown to improve erectile function in some preclinical studies. However, inadequate cell homing to damaged sites limited its functions. The investigators explore the effect of HUCMSC on improving erectile function of diabetic men, and whether collagen scaffolds contribute to long-term cell retention in the corpus cavernous and improves erectile function of diabetic men.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
The subjects will receive intracavernous injection of HUCMSC.'
The subjects will receive intracavernous injection of the mixture of collagen scaffolds and HUCMSC respectively.'
Drum Tower Hospital
Nanjing, Jiangsu, China
Improvements in IIEF scores
The subjects must fill in the questionnaire of IIEF-5 every visit to evaluate erectile function.
Time frame: 1,3,6,9 and 12 months
Penile colour Doppler ultrasonography combined with prostaglandin-E1 injection
Time frame: 1,3,6,9 and 12 months
Safety and Tolerability assessed by Adverse Events
Time frame: 1 month after intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.